Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Dow
Mallinckrodt
McKesson
Johnson and Johnson
Harvard Business School
Baxter

Last Updated: March 22, 2023

Famotidine - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic drug sources for famotidine and what is the scope of freedom to operate?

Famotidine is the generic ingredient in twelve branded drugs marketed by Akorn, Amneals Pharms, Lupin Ltd, Navinta Llc, Novel Labs Inc, Novitium Pharma, Salix Pharms, Apotex Inc, Apothecon, Athenex Inc, Fresenius Kabi Usa, Hikma, Hospira, Mylan Labs Ltd, Zydus Pharms, Abbvie, Baxter Hlthcare, Merck, Merck Sharp Dohme, Perrigo, J And J Consumer Inc, Ucb Inc, Actavis Elizabeth, Alembic Pharms Ltd, Alkem Labs Ltd, Annora Pharma, Apotex, Ascent Pharms Inc, Aurobindo Pharma, Aurobindo Pharma Ltd, Carlsbad, Celltrion, Dr Reddys Labs Ltd, Glenmark Pharms Inc, Ivax Sub Teva Pharms, Mankind Pharma, Mylan, Mylan Pharms Inc, P And L, Perrigo R And D, Rising, Sandoz, Sun Pharm Inds Ltd, Sun Pharm Industries, Teva, Vkt Pharma, Watson Labs, Bausch, Horizon, and Teva Pharms Usa, and is included in eighty NDAs. There are six patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are eighteen drug master file entries for famotidine. One hundred and thirteen suppliers are listed for this compound.

Drug Prices for famotidine

See drug prices for famotidine

Drug Sales Revenue Trends for famotidine

See drug sales revenues for famotidine

Recent Clinical Trials for famotidine

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Mainline Biosciences, Inc.Early Phase 1
Assistance Publique - Hôpitaux de ParisPhase 2/Phase 3
INSERM U 1163 - Laboratory of molecular mechanisms of hematologic disorders and therapeutic implications, ParisPhase 2/Phase 3

See all famotidine clinical trials

Pharmacology for famotidine
Medical Subject Heading (MeSH) Categories for famotidine

US Patents and Regulatory Information for famotidine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dr Reddys Labs Ltd FAMOTIDINE famotidine TABLET;ORAL 075718-002 Apr 16, 2001 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Abbvie FAMOTIDINE PRESERVATIVE FREE IN PLASTIC CONTAINER famotidine INJECTABLE;INJECTION 075729-001 Dec 17, 2001 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Zydus Pharms FAMOTIDINE famotidine TABLET;ORAL 216441-001 Jun 3, 2022 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for famotidine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
J And J Consumer Inc PEPCID AC famotidine TABLET, CHEWABLE;ORAL 020801-001 Sep 24, 1998 See Plans and Pricing See Plans and Pricing
J And J Consumer Inc PEPCID AC famotidine TABLET;ORAL 020325-001 Apr 28, 1995 See Plans and Pricing See Plans and Pricing
J And J Consumer Inc PEPCID AC famotidine TABLET;ORAL 020902-001 Aug 5, 1999 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Colorcon
Medtronic
Merck
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.